June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Increased Wnt Modulators in Patients with Diabetic Macular Edema
Author Affiliations & Notes
  • Bokjun Ji
    Ophthalmology, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea (the Republic of)
  • Jiyoung Lee
    Ophthalmology, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea (the Republic of)
  • Daehan Lim
    Ophthalmology, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea (the Republic of)
  • Hyung chan Kim
    Ophthalmology, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea (the Republic of)
  • Hyewon Chung
    Ophthalmology, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships Bokjun Ji, None; Jiyoung Lee, None; Daehan Lim, None; Hyung chan Kim, None; Hyewon Chung, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4294. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bokjun Ji, Jiyoung Lee, Daehan Lim, Hyung chan Kim, Hyewon Chung; Increased Wnt Modulators in Patients with Diabetic Macular Edema. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4294. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The Wnt pathway has been linked to numerous cellular processes, including angiogenesis, inflammation, and cellular survival. Its association with pathogenesis of diabetic retinopathy (DR) has been described. We previously showed that the levels of Wnt inhibitory factor 1 (WIF-1) and Dickkopf 3 (DKK-3) were significantly elevated in aqueous humor (AH) of neovascular age-related macular degeneration (nAMD) patients. In addition, the increased expression of WIF-1 and DKK-3 were correlated with the severity of outer retinal damage in nAMD. This study investigated the association between diabetic macular edema (DME) and levels of WIF-1 and DKK-3 in the AH of patients with DME and in the retina of diabetic animal models.

Methods: Twenty-eight eyes of twenty-three DME patients and 28 eyes of 28 age- and sex-matched controls were studied. AH WIF-1 and DKK-3 levels were measured by ELISA before the first intravitreal injection of bevacizumab. The levels of WIF-1 and DKK-3 and Wnt activation in the retina of Akita mice, a genetic model of type 1 diabetes, were measured by Western blot.

Results: ELISA analysis showed increased levels of WIF-1 and DKK-3 in 28 patients with DME compared to the 28 controls (64.3±13.6 ng/mL vs. 22.2±90.3 ng/mL and 161.4±19.4 ng/mL vs. 101.6±38.3 ng/mL, respectively, both p < 0.0001). Western blot revealed that the levels of WIF-1, DKK-3, and active β-catenin were increased in the retina of Akita mice compared to control mice.

Conclusions: In the AH of DME patients and the retina of animal models, WIF-1 and DKK-3 were upregulated, possibly modulating the upregulation of Wnt signaling in DME. Wnt antagonists have been considered as potential treatments for DR. Our study suggests that WIF-1 and DKK-3 might have therapeutic potential as the treatment for DR.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×